Holderness Investments Company’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,972
Closed -$252K 194
2022
Q1
$252K Sell
1,972
-80
-4% -$8.75K 0.08% 190
2021
Q4
$275K Hold
2,052
0.08% 197
2021
Q3
$281K Sell
2,052
-8
-0.4% -$1.01K 0.09% 183
2021
Q2
$220K Buy
+2,060
New +$198K 0.07% 206

Other funds holding DXCM

Holderness Investments Company's DXCM Position: Q2 2022 in Review

Holderness Investments Company sold out of DexCom (DXCM) in Q2 2022, closing a stake of 1,972 shares — an estimated $252K sold.

Holderness Investments Company first reported a position in DXCM in Q2 2021 and held it in 4 quarters. The position peaked at $281K in Q3 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Holderness Investments Company reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Holderness Investments Company sold 1,972 DexCom shares in Q2 2022, an estimated $252K.
  • Holderness Investments Company first reported a position in DexCom in Q2 2021 and held it in 4 quarters.
  • Holderness Investments Company's DexCom position peaked at $281K in Q3 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Holderness Investments Company's 13F filing for Q2 2022, filed 15 Aug 2022.